Latest Sustainable Growth News

Native Mineral Resources has surpassed 1,000 ounces of gold production at its Blackjack Gold Project, marking a key transition to steady-state operations. The company is also advancing critical infrastructure and environmental approvals to support future growth.

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.

Ryman Healthcare has reported its first positive free cash flow in over a decade, driven by cost reductions and stronger sales momentum, while upgrading its sales guidance for FY26.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.

Beacon Minerals Limited reports a substantial 276% increase in gold resources alongside strategic exploration and development plans, setting the stage for extended mine life and shareholder returns.

Harvey Norman Holdings detailed its expansive international growth and omni-channel strategy at its 2025 AGM, highlighting new flagship stores and AI-driven retail innovations across eight countries.

Select Harvests Limited reported a robust FY2025 with a 32.4% almond price surge driving a $30.9 million NPAT increase and halving net debt. The company’s strategic investments and operational efficiencies position it well for a positive FY2026 outlook.

Temple & Webster Group has reported a record FY25 revenue of $601 million, marking a 21% increase year-on-year, alongside a 43% rise in EBITDA. The company is confidently progressing towards its ambitious $1 billion mid-term revenue target.

Macquarie Technology Group unveiled ambitious plans to expand its AI-optimised data centre footprint, supported by a $450 million debt facility and strong growth across its cloud, government cybersecurity, and telecom divisions.

Jameson Resources Limited has updated its Employee Share Option Plan, approved at the 2025 AGM, aiming to better incentivize and retain key personnel while aligning employee interests with shareholders.

Comms Group reported robust FY25 results driven by domestic expansion, including the strategic acquisition of TasmaNet, and strong international growth in its Global and Wholesale division.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.